The Institute of Cancer Research, London, has earned the most staff-adjusted invention income of any UK higher education institution for the eighth year in a row.
A higher education institution’s invention income is a key marker of its success at commercialising its research for public benefit through collaboration with industry.
We have advised leading European 10-minute grocery delivery platform Dija on its successful exit to dominant US player, Gopuff. Having initially advised the business on its $20 million seed round in December 2020, we provided support through the company's rapid growth and significant European expansion ahead of guiding it through its exit.
OrderYOYO, a leading European online ordering, payment, and marketing software solution provider listed on Nasdaq Nordic, has, through its German subsidiary OrderYOYO Deutschland GmbH, acquired white-label software online ordering company Happz by way of an asset deal. The international law firm Taylor Wessing, led by Munich-based partner Philip Cavaillès, advised OrderYOYO on all German related aspects of the transaction.
2021 exhibition will open at Cromwell Place arts hub, South Kensington in November.
Cambridge UK: 27 August 2021
Appleyard Lees has become a Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs of the Partner and One Nucleus members.
Arecor Therapeutics plc
(“Arecor”, the “Company” or the “Group”)
APPOINTMENT OF GRANT THORNTON AS AUDITOR
Cambridge, UK, 27 August 2021: Arecor Therapeutics plc (AIM: AREC), a globally focused biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that Grant Thornton UK LLP (“Grant Thornton”) have been appointed as the Group’s auditor, with immediate effect. Lakin Rose Limited has resigned as the auditor of Arecor Limited.
NOTTINGHAM, U.K.; Aug. 25, 2021 – Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three years.
Biochemically defined and animal-free - Mussel Adhesive Protein based matrix (MAPtrix™) from AMSBIO provides a highly defined and controllable recombinant extracellular matrix (ECM) for cell culture, which can be tailored to the specific needs of particular cell types.
Sygnature Discovery Ltd has entered a collaboration with Epigeneron Inc., a leading Japanese bio-venture company that uses a unique cutting-edge technology to identify potential drug targets that regulate the expression of disease-related genes.
The two companies have signed a multi-project collaboration agreement to develop small molecule compounds of novel targets identified by Epigeneron’s unique technology, combined with the expertise of Sygnature’s highly experienced scientists.